Ihuman Inc Stock Current Liabilities
IH Stock | USD 1.52 0.03 1.94% |
Ihuman Inc fundamentals help investors to digest information that contributes to Ihuman's financial success or failures. It also enables traders to predict the movement of Ihuman Stock. The fundamental analysis module provides a way to measure Ihuman's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ihuman stock.
The current Total Current Liabilities is estimated to decrease to about 410.5 M. The current Non Current Liabilities Total is estimated to decrease to about 1.8 M. Ihuman | Current Liabilities |
Ihuman Inc Company Current Liabilities Analysis
Ihuman's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Ihuman Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for Ihuman is extremely important. It helps to project a fair market value of Ihuman Stock properly, considering its historical fundamentals such as Current Liabilities. Since Ihuman's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ihuman's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ihuman's interrelated accounts and indicators.
Click cells to compare fundamentals
Ihuman Current Liabilities Historical Pattern
Today, most investors in Ihuman Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ihuman's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Ihuman current liabilities as a starting point in their analysis.
Ihuman Current Liabilities |
Timeline |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition |
Ihuman Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, Ihuman Inc has a Current Liabilities of 0.0. This is 100.0% lower than that of the Hotels, Restaurants & Leisure sector and 100.0% lower than that of the Consumer Discretionary industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Ihuman Current Valuation Drivers
We derive many important indicators used in calculating different scores of Ihuman from analyzing Ihuman's financial statements. These drivers represent accounts that assess Ihuman's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Ihuman's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 5.0B | 5.4B | 941.4M | 955.9M | 1.2B | 1.2B | |
Enterprise Value | 4.9B | 4.5B | 120.3M | (85.0M) | 7.9M | 7.5M |
Ihuman Fundamentals
Return On Equity | 0.15 | ||||
Return On Asset | 0.0456 | ||||
Profit Margin | 0.14 % | ||||
Operating Margin | 0.09 % | ||||
Current Valuation | (76.09 M) | ||||
Shares Outstanding | 23.57 M | ||||
Shares Owned By Institutions | 0.61 % | ||||
Number Of Shares Shorted | 4.44 K | ||||
Price To Earning | 7.83 X | ||||
Price To Book | 0.63 X | ||||
Price To Sales | 0.08 X | ||||
Revenue | 1.02 B | ||||
Gross Profit | 660.62 M | ||||
EBITDA | 171.58 M | ||||
Net Income | 180.91 M | ||||
Cash And Equivalents | 1.05 B | ||||
Cash Per Share | 16.08 X | ||||
Total Debt | 3.86 M | ||||
Debt To Equity | 0.03 % | ||||
Current Ratio | 2.27 X | ||||
Book Value Per Share | 17.36 X | ||||
Cash Flow From Operations | 172.12 M | ||||
Short Ratio | 0.17 X | ||||
Earnings Per Share | (0.16) X | ||||
Target Price | 3.86 | ||||
Number Of Employees | 783 | ||||
Beta | 0.47 | ||||
Market Capitalization | 79.6 M | ||||
Total Asset | 1.45 B | ||||
Retained Earnings | (140.46 M) | ||||
Working Capital | 891.68 M | ||||
Annual Yield | 0.06 % | ||||
Net Asset | 1.45 B |
About Ihuman Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ihuman Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ihuman using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ihuman Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Ihuman Piotroski F Score and Ihuman Altman Z Score analysis. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.40) | Earnings Share (0.16) | Revenue Per Share 18.263 | Quarterly Revenue Growth (0.11) | Return On Assets 0.0456 |
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.